what's bitcoins, Knowledge

Goldman Sachs: I don't agree that gold can't reach $3,000 under a strong dollar. Goldman Sachs said that we don't agree with the view that the price of gold can't rise to $3,000 per ounce by the end of 2025 when the dollar remains strong for a long time. We predict that gold will reach $3,000 per ounce by the end of 2025, and the reduction of interest rate cuts by the Federal Reserve (rather than the strengthening of the US dollar) is the downside risk of this prediction.Trump appointed TOM BARRACK as the US ambassador to Turkey.Guotai Junan's annual strategy for innovative drugs in 2025: innovative pharmaceutical companies have accelerated into the harvest period, and the valuation has been at a historical low in the past five years. Guotai Junan said that the centralized purchasing policy has become stable, mature and normalized, and the marginal impact has weakened. Innovative drugs have gained policy inclination in the medical insurance negotiation. In the past two years, the policy has continued to promote pharmaceutical innovation, and the top-level design and local supporting chain support the development of innovative drugs. Commercial insurance is expected to bring new growth momentum to China's pharmaceutical market, and the overall industry trend is upward. At present, the trend of innovative drug industry is improving, the supply continues to accelerate, and a number of domestic innovative drugs are approved soon, which is expected to drive a new round of heavy volume. At the same time, the commercialization has achieved remarkable results and has occupied a dominant position in some sub-sectors. Pharma's performance continued to differentiate, and innovative drugs and just-needed drugs performed well. Biotech commercialization continues to increase, per capita yield continues to increase, the node of turning losses is approaching, and innovation ushers in the harvest period. Horizontal comparison: compared with overseas peers, the overall valuation of domestic innovative pharmaceutical companies is in a historically low range; Vertical comparison: the valuation of SW- pharmaceutical biology and SW- chemical preparations is at a historical low in the past five years, and it is expected that the valuation of subsequent sectors will pick up.

Japanese manufacturers' confidence index turned negative to the central bank's forecast in December. A short-term survey in Reuters, Japan, found that Japanese manufacturers' business confidence deteriorated further in December due to concerns about US protectionist policies. The survey of 505 large Japanese non-financial enterprises showed that manufacturers' confidence index fell from 5 in November to -1 in December, which was the first time since last February, and the number of pessimists exceeded optimists for the first time in 10 months. The loss of business confidence may cast a shadow over the Bank of Japan's forecast. The Bank of Japan had previously predicted that a steady recovery driven by rising wages and consumption would help inflation reach the 2% target in a sustainable way and justify further interest rate hikes. Many manufacturing industries have reported that business confidence has declined. Among electronic machinery manufacturers, steel and non-ferrous metal manufacturers, pessimists far exceed optimists.Guotai Junan: From policy expectation to focusing on performance, the marginal improvement of mass goods, Guotai Junan said, from policy expectation to focusing on performance, the marginal improvement of mass goods, stable drinks, marginal decline of alcohol, configuration: mass goods > beer & drinks > liquor, first grow before value, first choose snacks, certain preferred condiments, drinks and beer, and gradually lay out liquor: under low expectation, the layout is oversold and the valuation target is low, which is steady. Popular products: 1) Snacks and some condiments are preferred. 2) beer and drinks. 3) tobacco.Australia's S&P/ASX200 index opened down 12.60 points, or 0.15%, at 8380.4 points on Wednesday, December 11th.

The reporter explored: optimizing the transaction structure, the second-hand housing has become a hot spot in the market. "After the recent new property market policy, especially the reduction of transaction tax burden such as value-added tax, the second-hand housing is particularly popular." A senior real estate agent manager in Jindaotian District, Luohu District, Shenzhen, told the reporter, "Take several shed-reformed communities here as an example. Recently, more than 20 second-hand houses can be sold in each community every month. The price is low, the house is new and the location belongs to the urban area, which is very suitable for those who just need to buy a home." According to the data of Shenzhen Zhongyuan Research Center, the unit price of second-hand houses in the range of 40,000 yuan to 60,000 yuan accounted for 32.1% in November, ranking first and the increase was the most obvious. The transaction of new houses with a "building age" of less than 10 years was the most active. The reporter found out that in the second-hand housing market in several key cities, the transactions of new second-hand houses with relatively new "building age" are more active. Take Tianhe Park, a plate with high popularity of second-hand houses in Guangzhou, as an example. According to shell data, 41 sets were sold in this plate in October, a significant increase of 127.8% from the previous month. According to Yan Yuejin, vice president of Shanghai Yiju Real Estate Research Institute, the adjustment of tax policy will accelerate the listing of second-hand houses and good houses, which in turn will help buyers subscribe for second-hand houses and large-sized houses, which will have a positive effect on optimizing the transaction structure of second-hand houses and boosting second-hand housing transactions. (e company)SpaceX is valued at about $350 billion due to internal stock sales. According to an email sent to employees seen by the media, SpaceX and its investors have agreed to acquire the company's common stock of up to $1.25 billion at a price of $185 per share. This transaction values elon musk's rocket and satellite manufacturer at about $350 billion.Ministry of Finance of Korea: Korea's financial market is still facing uncertainty.